With the 2023 revisions to EU GMP Annex 1: Manufacture of Sterile Medicinal Products, there has been increased emphasis on continuous viable air monitoring as part of cleanroom environmental monitoring programs. TRIO.BAS™ offers advanced viable air-sampling solutions engineered to support compliance with these revised standards. Ahead, we’ll see how these instruments perform and reinforce Annex 1’s core expectations.
The updated EU GMP Annex 1 (sections 9.22 and 9.24) emphasizes:
TRIO.BAS™ offers a suite of continuous air microbial monitoring systems built to satisfy Annex 1 mandates: Multi-Head Sampling for Less Intervention Models like AIRBIO DUO, TRIO, and RABS ISOLATOR CM feature multiple aspirating heads or satellites to:
Continuous air sampling risks dehydrating agar media, which can compromise microbial recovery. TRIO.BAS™ units mitigate this by operating at a lower flow rate of 25 liters/minute, helping to preserve media integrity throughout monitoring.
The RABS ISOLATOR CM system supports attachment of up to three satellite units, providing flexible placement across risk-prone zones while centralizing control.2
TRIO.BAS™ systems come with:
Sources:
1. European Commission. (2022, August 25). EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use: Annex 1 — Manufacture of sterile medicinal products. https://www.gmp-compliance.org/files/guidemgr/20220825_gmp-an1_en_0.pdf
2. TRIO.BAS. (n.d.). RABS ISOLATOR CM system: Continuous air microbial monitoring [Product information]. TRIO.BAS. https://www.triobas.com/products/continuous-air-microbial-monitoring
3. Brackeen, Joelle. “Are You Annex 1 Ready? Continuous Air Monitoring for Viable Particulates.” Hardydiagnostics.com, Hardy Diagnostics, 28 Jan. 2026, hardydiagnostics.com/blog/annex-1-compliance-continuous-air-monitoring-for-viable-particulates
Read More >